NASDAQ · Price History

Polaryx Therapeutics, Inc. (PLYX) Stock Price History & Returns

$1.60 NASDAQ: PLYX Market Cap $79.75M

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Polaryx Therapeutics, Inc. (PLYX) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $1.60 sits 0% of the way up a 52-week range of $1.60 to $48.91; 96.7% below the 52-week high; below its 50-day moving average of $1.97; below its 200-day average of $3.56; a beta of -8.28 means it has historically moved opposite the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-25.9%
6 months-59.4%

Monthly closing prices

The last 10 months, newest first. 2 of 9 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$1.60-8.6%
October 2026$1.75-15.5%
September 2026$2.07+3.0%
August 2026$2.01-13.0%
July 2026$2.31-13.2%
June 2026$2.66-18.7%
May 2026$3.27-37.7%
April 2026$5.25-30.6%
March 2026$7.56+147.9%
February 2026$3.05—

Polaryx Therapeutics, Inc. (PLYX) price history — frequently asked questions

How has Polaryx Therapeutics, Inc. performed over the last year?

Polaryx Therapeutics, Inc. (PLYX) has risen 0.0% over the last twelve months, measured on price alone.

What is Polaryx Therapeutics, Inc.'s five-year return?

Over five years the PLYX share price has gained 0.0%, excluding dividends.

What is Polaryx Therapeutics, Inc.'s 52-week range?

Over the last year Polaryx Therapeutics, Inc. (PLYX) has traded between $1.60 and $48.91.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.